LONDON, UK / ACCESSWIRE / December 22, 2017 / Active-Investors free stock reports for this morning include these Toronto Exchanges’ equities from the Autos industry: New Flyer Industries, Exco Technologies, BRP Inc., and AutoCanada. Access our complimentary up-to-the-minute research reports by becoming an online member now:

www.active-investors.com/registration-sg

The S&P/TSX Composite Index progressed 22.96 points, or 0.14%, to close Thursday’s trading session at 16,182.63. The TSX Venture Exchange shaved off 1.55 points, or 0.19%, to finish at 804.14.

Today’s stocks of interest consist of New Flyer Industries Inc. (TSX: NFI), Exco Technologies Ltd (TSX: XTC), BRP Inc. (TSX: DOO), and AutoCanada Inc. (TSX: ACQ). Click the link below to view a sample of the free research report that will be available to you as a member of Active-Investors:

www.active-investors.com/registration-sg

New Flyer Industries Inc.

Winnipeg, Canada headquartered New Flyer Industries Inc.’s stock edged 0.22% lower, to finish Thursday’s session at $54.10 with a total volume of 71,983 shares traded. Over the last month and the previous three months, New Flyer Industries’ shares have gained 9.98% and 7.43%, respectively. Furthermore, the stock has surged 35.25% in the past year. The Company’s shares are trading above its 50-day and 200-day moving averages. New Flyer Industries’ 200-day moving average of $52.56 is above its 50-day moving average of $51.83. Shares of the Company, which manufactures and sells transit buses and motor coaches in the US and Canada, are trading at a PE ratio of 21.61. View the research report on NFI.TO at:

www.active-investors.com/registration-sg/?symbol=NFI

Exco Technologies Ltd

On Thursday, shares in Markham, Canada-based Exco Technologies recorded a trading volume of 46,398 shares. The stock ended the day 0.20% lower at $9.82. The Company’s shares are trading below its 50-day and 200-day moving averages. The stock’s 200-day moving average of $10.24 is above its 50-day moving average of $9.96. Shares of Exco Technologies, which together with its subsidiaries, designs, develops, manufactures and sells dies, molds, components and assemblies, and consumable equipment for the die-cast, extrusion, and automotive industries, are trading at a PE ratio of 9.84.

Get the free report on XTC.TO at:

www.active-investors.com/registration-sg/?symbol=XTC

BRP Inc.

On Thursday, shares in Valcourt, Canada headquartered BRP Inc. ended the session 0.02% higher at $47.40 with a total volume of 77,813 shares traded. BRP’s shares have advanced 2.98% in the last month and 15.75% in the previous three months. Furthermore, the stock has surged 67.67% in the past one year. The stock is trading above its 50-day and 200-day moving averages. Moreover, the stock’s 50-day moving average of $46.32 is greater than its 200-day moving average of $41.75. Shares of the Company, which together with its subsidiaries, designs, develops, manufactures, distributes, and markets powersports vehicles and propulsion systems worldwide, are trading at a PE ratio of 17.67. Access the most recent report coverage on DOO.TO at:

www.active-investors.com/registration-sg/?symbol=DOO

AutoCanada Inc.

Edmonton, Canada headquartered AutoCanada Inc.’s stock closed the day 0.61% higher at $23.17. The stock recorded a trading volume of 66,847 shares. The Company’s shares are trading above their 200-day moving average. Moreover, the stock’s 50-day moving average of $23.69 is greater than its 200-day moving average of $21.70. Shares of the Company, which through its subsidiaries, operates franchised automobile dealerships in Canada, are trading at a PE ratio of 11.70. Today’s complimentary report on ACQ.TO can be accessed at:

www.active-investors.com/registration-sg/?symbol=ACQ

Active-Investors:

Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles, and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

A-I has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charter-holder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://active-investors.com/legal-disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@active-investors.com

Phone number: 73 29 92 6381

Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active-Investors

ReleaseID: 484830

LONDON, UK / ACCESSWIRE / December 22, 2017 / Active-Investors free stock reports for this morning include these Toronto Exchanges’ equities from the REITs industry: American Hotel Income Properties REIT, Killam Apartment REIT, Slate Office REIT, and Choice Properties REIT. Access our complimentary up-to-the-minute research reports by becoming an online member now:

www.active-investors.com/registration-sg

The S&P/TSX Composite Index progressed 22.96 points, or 0.14%, to close Thursday’s trading session at 16,182.63. The TSX Venture Exchange shaved off 1.55 points, or 0.19%, to finish at 804.14.

Today’s stocks of interest consist of American Hotel Income Properties REIT L.P. (TSX: HOT-UN), Killam Apartment Real Estate Investment Trust (TSX: KMP-UN), Slate Office REIT (TSX: SOT-UN), and Choice Properties Real Estate Investment Trust (TSX: CHP-UN). Click the link below to view a sample of the free research report that will be available to you as a member of Active-Investors:

www.active-investors.com/registration-sg

American Hotel Income Properties REIT L.P.

Vancouver, British Columbia-based American Hotel Income Properties REIT L.P.’s stock edged 0.54% lower, to finish Thursday’s session at $9.16 with a total volume of 163,611 shares traded. The Company’s shares are trading below its 50-day and 200-day moving averages. American Hotel Income Properties’ 200-day moving average of $9.52 is above its 50-day moving average of $9.20. Shares of the Company, which invests in the real estate markets across US, are trading at a PE ratio of 61.89. View the research report on HOT-UN.TO at:

www.active-investors.com/registration-sg/?symbol=HOT.UN

Killam Apartment Real Estate Investment Trust

On Thursday, shares in Halifax, Canada headquartered Killam Apartment Real Estate Investment Trust, which owns, manages and develops multi-family residential properties in across Canada and operates MHC communities in Ontario and Eastern Canada, recorded a trading volume of 163,162 shares during the session. The stock ended the day 0.21% higher at $14.15. Get the free report on KMP-UN.TO at:

www.active-investors.com/registration-sg/?symbol=KMP.UN

Slate Office REIT

On Thursday, shares in Toronto, Canada headquartered Slate Office REIT ended the session flat at $8.11 with a total volume of 85,414 shares traded. Slate Office REIT’s shares have advanced 1.50% in the last three months and 4.51% in the previous year. The stock is trading above its 200-day moving average. Furthermore, the stock’s 50-day moving average of $8.15 is greater than its 200-day moving average of $8.04. Shares of the Company, which focuses on the ownership and acquisition of industrial, office, and retail real estate primarily in Canada, are trading at a PE ratio of 7.74. Access the most recent report coverage on SOT-UN.TO at:

www.active-investors.com/registration-sg/?symbol=SOT.UN

Choice Properties Real Estate Investment Trust

Toronto, Ontario-based Choice Properties Real Estate Investment Trust’s stock closed the day 1.53% higher at $13.23. The stock recorded a trading volume of 98,367 shares, which was above its three months average volume of 42,323 shares. Choice Properties REIT’s shares have advanced 0.38% in the last three months. The Company’s shares are trading below their 50-day and 200-day moving averages. Moreover, the stock’s 200-day moving average of $13.39 is greater than its 50-day moving average of $13.31. Shares of the Company, which operates as an investment arm of Loblaws Inc., are trading at a PE ratio of 1.99. Today’s complimentary report on CHP-UN.TO can be accessed at:

www.active-investors.com/registration-sg/?symbol=CHP.UN

Active-Investors:

Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles, and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

A-I has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charter-holder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://active-investors.com/legal-disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@active-investors.com

Phone number: 73 29 92 6381

Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active-Investors

ReleaseID: 484831

LONDON, UK / ACCESSWIRE / December 22, 2017 / Active-Investors free stock reports for this morning include these Toronto Exchanges’ equities from the Asset Management industry: Sprott, Tricon Capital Group, Noranda Income Fund, and Canoe EIT Income Fund. Access our complimentary up-to-the-minute research reports by becoming an online member now:

www.active-investors.com/registration-sg

The S&P/TSX Composite Index progressed 22.96 points, or 0.14%, to close Thursday’s trading session at 16,182.63. The TSX Venture Exchange shaved off 1.55 points, or 0.19%, to finish at 804.14.

Moreover, the Financials index was up by 0.23%, closing at 309.68.

Today’s stocks of interest consist of Sprott Inc. (TSX: SII), Tricon Capital Group Inc. (TSX: TCN), Noranda Income Fund (TSX: NIF-UN), and Canoe EIT Income Fund (TSX: EIT-UN). Click the link below to view a sample of the free research report that will be available to you as a member of Active-Investors:

www.active-investors.com/registration-sg

Sprott Inc.

Toronto, Canada-based Sprott Inc.’s stock finished Thursday’s session flat at $2.30 with a total volume of 50,988 shares traded. Over the last month and the previous three months, Sprott’s shares have gained 2.69% and 10.05%, respectively. The Company’s shares are trading above its 50-day and 200-day moving averages. Sprott’s 50-day moving average of $2.25 is above its 200-day moving average of $2.21. Shares of the Company, which through its subsidiaries, the firm provides asset management, portfolio management, wealth management, fund management, and administrative and consulting services to its clients, are trading at a PE ratio of 15.54. View the research report on SII.TO at:

www.active-investors.com/registration-sg/?symbol=SII

Tricon Capital Group Inc.

On Thursday, shares in Toronto, Canada-based Tricon Capital Group Inc. recorded a trading volume of 308,804 shares, which was above their three months average volume of 185,050 shares. The stock ended the day 0.52% higher at $11.49. Tricon Capital’s stock has advanced 2.68% in the last month and 11.66% in the previous three months. Furthermore, the stock has gained 20.44% in the past year. The Company’s shares are trading above its 50-day and 200-day moving averages. The stock’s 50-day moving average of $11.23 is above its 200-day moving average of $10.96. Shares of Tricon Capital, which focuses on the residential real estate industry in North America, are trading at a PE ratio of 28.02. Get the free report on TCN.TO at:

www.active-investors.com/registration-sg/?symbol=TCN

Noranda Income Fund

On Thursday, shares in Toronto, Canada headquartered Noranda Income Fund ended the session flat at $1.41 with a total volume of 62,040 shares traded. Noranda Income Fund’s shares have advanced 2.17% in the past month. Shares of the Company, which operates as an income trust, are trading below its 50-day and 200-day moving averages. Furthermore, the stock’s 50-day moving average of $1.48 is greater than its 200-day moving average of $1.42. Access the most recent report coverage on NIF-UN.TO at:

www.active-investors.com/registration-sg/?symbol=NIF.UN

Canoe EIT Income Fund

Canoe EIT Income Fund’s stock closed the day 0.25% higher at $11.84. The stock recorded a trading volume of 151,682 shares, which was above its three months average volume of 106,473 shares. Canoe EIT Income Fund’s shares have advanced 0.77% in the last month and 4.13% in the past three months. The Company’s shares are trading above their 50-day and 200-day moving averages. Moreover, the stock’s 50-day moving average of $11.79 is greater than its 200-day moving average of $11.68. Shares of the Company, which objective of the Fund is to maximize monthly distributions relative to risk and maximize net asset value while maintaining and expanding a diversified portfolio, are trading at a PE ratio of 5.68. Today’s complimentary report on EIT-UN.TO can be accessed at:

www.active-investors.com/registration-sg/?symbol=EIT.UN

Active-Investors:

Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles, and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

A-I has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charter-holder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://active-investors.com/legal-disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@active-investors.com

Phone number: 73 29 92 6381

Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active-Investors

ReleaseID: 484832

LONDON, UK / ACCESSWIRE / December 22, 2017 / Active-Investors free stock reports for this morning include these Toronto Exchanges’ equities from the Metals & Mining industry: Osisko Gold Royalties, NovaGold Resources, Dundee Precious Metals, and Premier Gold Mines. Access our complimentary up-to-the-minute research reports by becoming an online member now:

www.active-investors.com/registration-sg

The S&P/TSX Composite Index progressed 22.96 points, or 0.14%, to close Thursday’s trading session at 16,182.63. The TSX Venture Exchange shaved off 1.55 points, or 0.19%, to finish at 804.14.

Moreover, the Mining index was up by 0.72%, closing at 131.65.

Today’s stocks of interest consist of Osisko Gold Royalties Ltd (TSX: OR), NovaGold Resources Inc. (TSX: NG), Dundee Precious Metals Inc. (TSX: DPM), and Premier Gold Mines Ltd (TSX: PG). Click the link below to view a sample of the free research report that will be available to you as a member of Active-Investors:

www.active-investors.com/registration-sg

Osisko Gold Royalties Ltd

Montreal, Canada headquartered Osisko Gold Royalties Ltd’s stock edged 0.14% lower, to finish Thursday’s session at $14.18 with a total volume of 152,289 shares traded. Osisko Gold Royalties’ shares have gained 17.58% in the past year. The Company’s shares are trading below its 50-day and 200-day moving averages. Osisko Gold Royalties’ 200-day moving average of $15.94 is above its 50-day moving average of $15.07. Shares of the Company, which acquires and manages precious metal and other royalties and streams, and similar interests in the Americas, are trading at a PE ratio of 54.75. View the research report on OR.TO at:

www.active-investors.com/registration-sg/?symbol=OR

NovaGold Resources Inc.

On Thursday, shares in Vancouver, Canada-based NovaGold Resources Inc. ended the session flat at $5.14 with a total volume of 100,554 shares traded. NovaGold Resources’ shares have advanced 5.11% in the last month and 2.59% in the previous three months. Shares of the Company, which explores and develops mineral properties in Canada and the US, are trading above its 50-day moving average. Furthermore, the stock’s 200-day moving average of $5.30 is greater than its 50-day moving average of $4.94. Get the free report on NG.TO at:

www.active-investors.com/registration-sg/?symbol=NG

Dundee Precious Metals Inc.

On Thursday, shares in Toronto, Canada headquartered Dundee Precious Metals Inc. recorded a trading volume of 455,295 shares, which was above their three months average volume of 133,846 shares. The stock ended the day 1.70% higher at $2.99. Dundee Precious Metals’ stock has advanced 3.46% in the last month and 22.54% in the previous three months. Furthermore, the stock has surged 50.25% in the previous year. Shares of the Company, which engages in the acquisition, exploration, development, mining, and processing of precious metals, are trading above its 50-day and 200-day moving averages. The stock’s 50-day moving average of $2.80 is above its 200-day moving average of $2.60. Access the most recent report coverage on DPM.TO at:

www.active-investors.com/registration-sg/?symbol=DPM

Premier Gold Mines Ltd

Thunder Bay, Canada headquartered Premier Gold Mines Ltd’s stock closed the day 1.28% lower at $3.85. The stock recorded a trading volume of 258,398 shares. Premier Gold Mines’ shares have advanced 6.06% in the last month and 7.24% in the past three months. Furthermore, the stock has surged 69.60% in the previous year. The Company’s shares are trading above their 50-day and 200-day moving averages. Moreover, the stock’s 50-day moving average of $3.54 is greater than its 200-day moving average of $3.43. Shares of the Company, which explores for, develops, and produces gold and silver deposits in Canada, the US, and Mexico, are trading at a PE ratio of 15.16. Today’s complimentary report on PG.TO can be accessed at:

www.active-investors.com/registration-sg/?symbol=PG

Active-Investors:

Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles, and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

A-I has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charter-holder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://active-investors.com/legal-disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@active-investors.com

Phone number: 73 29 92 6381

Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active-Investors

ReleaseID: 484833

Stock Monitor: The RMR Group Post Earnings Reporting

LONDON, UK / ACCESSWIRE / December 22, 2017 / Active-Investors.com has just released a free earnings report on Invitation Homes Inc. (NYSE: INVH). If you want access to this report all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=INVH . The Company posted its financial results on November 08, 2017, for the third quarter of the fiscal year 2017. The real estate investment trust’s total revenue surpassed analysts’ expectations. Register today and get access to over 1000 Free Research Reports by joining our site below:

www.active-investors.com/registration-sg

Active-Investors.com is currently working on the research report for The RMR Group Inc. (NASDAQ: RMR), which also belongs to the Financial sector as the Company Invitation Homes. Do not miss out and become a member today for free to access this upcoming report at:

www.active-investors.com/registration-sg/?symbol=RMR

Active-Investors.com is focused on giving you timely information and the inside line on companies that matter to you. This morning, Invitation Homes most recent news is on our radar and our team decided to put out a fantastic report on the company that is now available for free below:

www.active-investors.com/registration-sg/?symbol=INVH

Earnings Highlights and Summary

For the three months ended September 30, 2017, Invitation Homes’ total revenues increased 4.5% to $243.54 million from $233.04 million in Q3 FY16. The Company’s total revenue numbers surpassed analysts’ expectations of $242.83 million.

During Q3 FY17, Invitation Homes’ net operating income (NOI) increased 8.3% to $150.27 million from $138.79 million in the same period of last year.

For the reported quarter, Invitation Homes’ earnings before interest, tax, depreciation, and amortization (EBITDA) decreased 9.9% to $101.75 million from $112.90 million in Q3 FY16. For the reported quarter, the Company’s EBITDA margin decreased 660 basis points to 41.8% of revenue from 48.4% of revenue in Q3 FY16. For the reported quarter, Invitation Homes’ adjusted EBITDA increased 6.5% to $128.90 million from $121.06 million in Q3 FY16. For the reported quarter, the Company’s adjusted EBITDA margin increased 100 basis points to 52.9% of revenue from 51.9% of revenue in Q3 FY16.

During Q3 FY17, Invitation Homes’ operating income decreased 32.8% to $29.92 million from $44.51 million in the comparable period of last year. For the reported quarter, the Company’s operating margin decreased 680 basis points to 12.3% of revenue from 19.1% of revenue in Q3 FY16.

For the reported quarter, Invitation Homes’ net loss was $22.75 million compared to a net loss of $21.95 million in Q3 FY16. During Q3 FY17, the Company’s diluted earnings per share (EPS) was on par with the negative $0.07 reported in the corresponding period of last year.

For the reported quarter, Invitation Homes’ funds from operations (FFO) decreased 1.9% to $40.83 million from $41.61 million in Q3 FY16. During Q3 FY17, the Company’s FFO per share was on par with the $0.13 recorded in the same period of last year. For the reported quarter, Invitation Homes’ core FFO increased 20.3% to $75.38 million on a y-o-y basis from $62.64 million in Q3 FY16. During Q3 FY17, the Company’s core FFO per share increased 20% to $0.24 from $0.20 in Q3 FY16, and was in-line with analysts’ expectations of $0.24.

For the reported quarter, Invitation Homes’ adjusted funds from operations (AFFO) increased 28.3% to $61.99 million on a y-o-y basis from $48.32 million in Q3 FY16. During Q3 FY17, the Company’s AFFO per share increased 25% to $0.20 from $0.16 in the comparable period of last year.

Segment Details

Same Store Portfolio – During Q3 FY17, the Company’s Same Store Portfolio’s total revenue increased 4.7% to $220.41 million from $210.50 million in the corresponding period of last year. For the reported quarter, the segment’s NOI increased 8.1% to $135.77 million from $125.61 million in Q3 FY16. For the reported quarter, the segment’s core NOI margin was 62.7% compared to 60.4% in Q3 FY16. For the reported quarter, the segment’s average occupancy was 95.4% compared to 95.5% in Q3 FY16.

Non-Same Store Portfolio – During Q3 FY17, the Company’s Non-Same Store Portfolio’s revenue increased 2.6% to $23.13 million from $22.54 million in the same period of last year. For the reported quarter, the segment’s NOI increased 10% to $14.50 million from $13.18 million in Q3 FY16.

Balance Sheet

As on September 30, 2017, Invitation Homes’ cash and cash equivalents decreased 32.1% to $134.44 million from $198.12 million as on December 31, 2016. For the reported quarter, the Company’s net mortgage loans decreased 20.9% to $4.16 billion from $5.25 million in Q4 FY16.

Outlook

For FY17, the Company expects core FFO per share to be in the range of $0.98 – $1.02, and AFFO per share to be in the band of $0.82 – $0.86. The Company estimates same-store revenue growth to be in the range of 4.7% – 4.9%, and same-store NOI growth to be in the band of 6.8% – 7.2% for the fiscal year 2017.

Stock Performance Snapshot

December 21, 2017 – At Thursday’s closing bell, Invitation Homes’ stock slightly climbed 0.34%, ending the trading session at $23.41.

Volume traded for the day: 5.36 million shares, which was above the 3-month average volume of 3.35 million shares.

Stock performance in the last month – up 0.17%; previous three-month period – up 5.69%; past six-month period – up 7.78%; and year-to-date – up 17.05%

After yesterday’s close, Invitation Homes’ market cap was at $11.97 billion.

The stock has a dividend yield of 1.37%.

The stock is part of the Financial sector, categorized under the Real Estate Development industry. This sector was up 0.7% at the end of the session.

Active-Investors:

Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles, and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

A-I has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charter-holder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://active-investors.com/legal-disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@active-investors.com

Phone number: 73 29 92 6381

Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active-Investors

ReleaseID: 484856

Stock Monitor: China Online Education Post Earnings Reporting

LONDON, UK / ACCESSWIRE / December 22, 2017 / Active-Investors.com has just released a free report on GP Strategies Corp. (NYSE: GPX). If you want access to this report all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=GPX. On December 20, 2017, the Company declared on December 20, 2017, that it struck an agreement to acquire certain assets and the business of Hula Partners. The transaction is likely to close on January 02, 2018, and is subject to certain closing conditions including obtaining certain consents and agreements. Register today and get access to over 1000 Free Research Reports by joining our site below:

www.active-investors.com/registration-sg

Active-Investors.com is currently working on the research report for China Online Education Group (NYSE: COE), which also belongs to the Services sector as the Company GP Strategies. Do not miss out and become a member today for free to access this upcoming report at:

www.active-investors.com/registration-sg/?symbol=COE

Active-Investors.com is focused on giving you timely information and the inside line on companies that matter to you. This morning, GP Strategies most recent news is on our radar and our team decided to put out a fantastic report on the company that is now available for free below:

www.active-investors.com/registration-sg/?symbol=GPX

Acquisition will Strengthen GP Strategies’ Ability to Deliver Comprehensive HCM Services

Hula brings deep complementary core HR technical and functional expertise to the existing GP Strategies SAP SuccessFactors team. Hula’s core HR migrations involve large multi-year projects, allowing for cross-selling opportunities to GP Strategies’ existing client base as well as recurring revenue opportunities for SuccessFactors support and optimization services. This acquisition will also strengthen GP Strategies’ ability to deliver comprehensive HCM services across its diverse global customer base.

Both the Companies Closely Aligned with Respect to Delivering High Quality Services

John Plusquellec, Managing Partner at Hula Partners, stated that the Company has found GP Strategies and Hula Partners to be very closely aligned with respect to delivering high quality services for all the customers. John added that Hula Partners can now offer its customers expanded certified consulting capability that delivers the best and most successful project experience across the globe.

GP Strategies’ Acquisitions in 2017

On September 05, 2017, the Company’s wholly-owned subsidiary, GP Strategies Training Limited, acquired the entire share capital of YouTrain Limited, an independent training company delivering IT, digital, and life sciences skills training throughout Scotland and North-West England. On the same day, GP Strategies acquired CLS Performance Solutions Limited, an independent provider of Enterprise Resource Planning end user adoption and training services in the United Kingdom.
On April 04, 2017, the Company completed the acquisition of certain assets and the business of Emantras, an innovative digital education company that provides engaging learning experiences, and effective knowledge delivery through award-winning digital and mobile solutions.

On February 02, 2017, GP Strategies completed the acquisition of McKinney Rogers, a results-driven global consultancy firm that provides strategy-through-implementation services with a proven track record of delivering tangible improvements in clients’ business results.

GP Strategies Announced $10 Million Increase in Share Repurchase Program

In November 2017, GP Strategies announced that its Board of Directors authorized a $10 million increase in funding for its share repurchase program, bringing the total authorization to approximately $13.6 million. The Company’s share repurchase program allows management, at its discretion in accordance with applicable federal securities law, to repurchase shares from time to time in the open market subject to market conditions and other factors. The Company expected to fund share repurchases using cash generated from operations and borrowings under its $100 million credit facility

About GP Strategies Corp.

Founded in 1966 and headquartered in Columbia, Maryland, GP Strategies is a global performance improvement company driven to solve organization’s business challenges, attain ultimate performance results and together make a greater impact. Serving more than 16 diverse industries, GP Strategies is a leader in sales and technical training, eLearning solutions, management consulting, and engineering services.

About Hula Partners

Hula Partners is a provider of HR software, strategic consultation, and SAP HCM & SuccessFactors implementation services. The Company draws on more than 80 years collective experience in providing global transformation services to oil and gas, aerospace and defense, among others. Hula Partners was established in 2012 and is headquartered in Houston, Texas.

Stock Performance Snapshot

December 21, 2017 – At Thursday’s closing bell, GP Strategies’ stock marginally fell 0.21%, ending the trading session at $23.55.

Volume traded for the day: 56.13 thousand shares, which was above the 3-month average volume of 44.99 thousand shares.

After yesterday’s close, GP Strategies’ market cap was at $383.63 million.

Price to Earnings (P/E) ratio was at 19.84.

The stock is part of the Services sector, categorized under the Education & Training Services industry. This sector was up 0.4% at the end of the session.

Active-Investors:

Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles, and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

A-I has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charter-holder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://active-investors.com/legal-disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@active-investors.com

Phone number: 73 29 92 6381

Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active-Investors

ReleaseID: 484851

LONDON, UK / ACCESSWIRE / December 22, 2017 / Active-Investors.com has just released a free earnings report on Haemonetics Corp. (NYSE: HAE). If you want access to this report all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=HAE . The Company posted its financial results for the second quarter fiscal 2018. The healthcare Company’s EPS surpassed analysts’ expectations. Register today and get access to over 1000 Free Research Reports by joining our site below:

www.active-investors.com/registration-sg

Active-Investors.com is focused on giving you timely information and the inside line on companies that matter to you. This morning, Haemonetics most recent news is on our radar and our team decided to put out a fantastic report on the company that is now available for free below:

www.active-investors.com/registration-sg/?symbol=HAE

Earnings Highlights and Summary

For three months ended September 30, 2017, Haemonetics’s net revenues increased 2.3%, or 2.1% on a constant currency basis, to $225.38 million from $220.25 million in Q2 FY17. The Company’s net revenue surpassed analysts’ expectations of $220 million.

For the reported quarter, the Company’s Plasma revenue increased 6%, or 5.7% on a constant currency basis, to $109.77 million from $103.56 million in Q2 FY17. For the reported quarter, the Company’s Blood center revenue decreased 3.4% to $71.71 million from $74.27 million in Q2 FY17. For the reported quarter, the Company’s Cell processing revenue decreased 0.7% to $25.76 million from $25.96 million in Q2 FY17. For the reported quarter, the Company’s Hemostasis Management revenue increased 10.1%, or 10.4% on a constant currency basis, to $18.13 million from $16.46 million in Q2 FY17.

During Q2 FY18, Haemonetics’s gross profit increased 0.3% to $104.56 million from $104.25 million in the same period last year. For the reported quarter, the Company’s gross margin decreased 90 basis points to 46.4% of revenue from 47.3% of revenue in Q2 FY17. During Q2 FY18, Haemonetics’s adjusted gross profit increased 0.4% to $104.77 million from $104.31 million in the same period last year. For the reported quarter, the Company’s adjusted gross margin decreased 90 basis points to 46.5% of revenue from 47.4% of revenue in Q2 FY17.

During Q2 FY18, Haemonetics’s operating income decreased 2.2% to $24.26 million from $24.79 million in the same period last year. For the reported quarter, the Company’s operating margin decreased 50 basis points to 10.8% of revenue from 11.3% of revenue in Q2 FY17. During Q2 FY18, Haemonetics’s adjusted operating income increased 9.3% to $36.55 million from $33.44 million in the same period last year. For the reported quarter, the Company’s adjusted operating margin increased 100 basis points to 16.2% of revenue from 15.2% of revenue in Q2 FY17.

For the reported quarter, Haemonetics’s EBT increased 0.1% to $22.86 million, from $22.83 million in Q2 FY17. For the reported quarter, the Company’s earnings before tax (EBT) margin decreased 30 basis points to 10.1% of revenue from 10.4% of revenue in Q2 FY17.

During Q2 FY18, Haemonetics’s net income increased 1.4% to $20.10 million on a y-o-y basis from $19.83 million in the same period last year. For the reported quarter, the Company’s diluted EPS was $0.38, on par with $0.38 in the second quarter of 2017. For the reported quarter, Haemonetics’s adjusted net income increased 9.1% to $25.67 million on a y-o-y basis from $23.52 million in Q2 FY17. During Q2 FY18, the Company’s adjusted diluted EPS increased 4.3% to $0.48 on a y-o-y basis from $0.46 in the same period last year. Adjusted diluted EPS surpassed analysts’ expectations of $0.41.

Balance Sheet

As on September 30, 2017, Haemonetics’s cash and cash equivalents increased 45.9% to $203.62 million from $139.56 million on January 04, 2017. For the reported quarter, the Company’s long-term debt decreased 29.8% to $178.02 million from $253.63 million in Q4 FY17.

For the reported quarter, the Company’s net accounts receivables decreased 5.9% to $143.69 million from $152.68 million in Q4 FY17.

During H1 FY18, the Company’s net cash provided by operating activities increased 39.1% to $97.33 million from $69.96 million in the same period last year. During H1 FY18, the Company’s free cash flow increased 143.8% to $69.55 million from $28.53 million in the same period last year.

Outlook

For FY18, the Company expects adjusted diluted EPS to be in the range of $1.65 to $1.75.

Stock Performance Snapshot

December 21, 2017 – At Thursday’s closing bell, Haemonetics’ stock advanced 1.47%, ending the trading session at $58.52.

Volume traded for the day: 254.69 thousand shares.

Stock performance in the last three-month – up 36.00%; previous six-month period – up 48.87%; past twelve-month period – up 42.98%; and year-to-date – up 45.57%

After yesterday’s close, Haemonetics’ market cap was at $3.08 billion.

Price to Earnings (P/E) ratio was at 812.78.

The stock is part of the Healthcare sector, categorized under the Medical Instruments & Supplies industry. This sector was up 0.1% at the end of the session.

Active-Investors:

Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles, and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

A-I has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charter-holder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://active-investors.com/legal-disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@active-investors.com

Phone number: 73 29 92 6381

Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active-Investors

ReleaseID: 484852

LONDON, UK / ACCESSWIRE / December 22, 2017 / Active-Investors.com has just released a free earnings report on Hologic, Inc. (NASDAQ: HOLX). If you want access to this report all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=HOLX . The Company posted its financial results on November 08, 2017, for the fourth quarter of the fiscal year 2017. The healthcare and diagnostics Company’s revenue and adjusted EPS surpassed analysts’ expectations. Register today and get access to over 1000 Free Research Reports by joining our site below:

www.active-investors.com/registration-sg

Active-Investors.com is focused on giving you timely information and the inside line on companies that matter to you. This morning, Hologic most recent news is on our radar and our team decided to put out a fantastic report on the company that is now available for free below:

www.active-investors.com/registration-sg/?symbol=HOLX

Earnings Highlights and Summary

For the three months ended September 30, 2017, Hologic’s total revenues increased 10.5%, or 9.9% on a constant currency basis, to $802.9 million from $726.8 million in Q4 FY16. The Company’s total revenue numbers surpassed analysts’ expectations of $793 million.

During Q4 FY17, Hologic’s gross profit increased 2.9% to $417.9 million from $406.1 million in the same period of last year. For the reported quarter, the Company’s gross margin decreased 390 basis points to 52.0% of revenue from 55.9% of revenue in Q4 FY16. For the reported quarter, the Company’s adjusted gross margin decreased 160 basis points to 64.1% of revenue from 65.7% of revenue in Q4 FY16, due to the divestiture of the blood screening business and revenues from low-margin Cynosure products.

For the reported quarter, Hologic’s adjusted earnings before interest, tax, depreciation, and amortization (EBITDA) decreased 0.5% to $262.7 million from $263.9 million in Q4 FY16. For the reported quarter, the Company’s adjusted EBITDA margin decreased 360 basis points to 32.7% of revenue from 36.3% of revenue in Q4 FY16.

During Q4 FY17, Hologic’s operating income decreased 25.6% to $109.4 million from $147.1 million in the comparable period of last year. For the reported quarter, the Company’s operating margin decreased 660 basis points to 13.6% of revenue from 20.2% of revenue in Q4 FY16. For the reported quarter, the Company’s adjusted operating margin decreased 350 basis points to 29.8% of revenue from 33.3% of revenue in Q4 FY16. The decrease was due to product and geography mix, as well as the divestiture of the Company’s blood screening business.

During Q4 FY17, Hologic’s earnings before tax (EBT) decreased 32.7% to $72.4 million from $107.6 million in the corresponding period of last year. For the reported quarter, the Company’s EBT margin decreased 580 basis points to 9% of revenue from 14.8% of revenue in Q4 FY16.

For the reported quarter, Hologic’s net income decreased 10.3% to $82.7 million from $92.2 million in Q4 FY16. During Q4 FY17, the Company’s diluted earnings per share (EPS) decreased 12.1% to $0.29 from $0.33 in the same period of last year. For the reported quarter, Hologic’s adjusted net income decreased 1.7% to $143.2 million from $145.7 million in Q4 FY16. During Q4 FY17, the Company’s adjusted diluted EPS decreased 3.8% to $0.50 from $0.52 in Q4 FY16, surpassing analysts’ expectations of $0.49.

Segment Details

Diagnostics – During Q4 FY17, the Company’s Diagnostics segment’s revenue decreased 6.5%, or 7% on a constant currency basis, to $291.7 million from $311.9 million in the comparable period of last year. For the reported quarter, the segment’s Molecular Diagnostics revenues increased 14.3% to $153.5 million on a y-o-y basis, due to an increasing market share and utilization of fully-automated Panther system.

Breast Health – During Q4 FY17, the Company’s Breast Health segment’s revenue increased 2.9%, or 2.4% on a constant currency basis, to $300.9 million from $292.3 million in the corresponding period of last year.

GYN Surgical Business – During Q4 FY17, the Company’s GYN Surgical Business segment’s revenue increased 3.2%, or 2.7% on a constant currency basis, to $104.7 million from $101.5 million in the same period of last year.

Balance Sheet

As on September 30, 2017, Hologic’s cash and cash equivalents decreased 1.4% to $540.6 million from $548.4 million as on September 24, 2016. For the reported quarter, the Company’s long-term debt, net of current portion, decreased 28.8% to $2.17 billion from $3.05 billion in Q4 FY16.

For the reported quarter, the Company’s net accounts receivables increased 19.4% to $533.5 million from $447.0 million in Q4 FY16. For the reported quarter, the Company’s accounts payable and accrued liabilities increased 22.2% to $543.5 million from $444.5 million in Q4 FY16.

During FY17, Hologic’s net cash provided by operating activities decreased 99% to $8.3 million from $798.2 million in FY16.

Outlook

For Q1 FY18, the Company expects diluted EPS to be in the range of $0.25 – $0.27, and adjusted diluted EPS to be in the band of $0.48 – $0.50.

For FY18, the Company expects diluted EPS to be in the range of $1.22 – $1.27, and adjusted diluted EPS to be in the band of $2.10 – $2.15.

Stock Performance Snapshot

December 21, 2017 – At Thursday’s closing bell, Hologic’s stock was slightly down 0.44%, ending the trading session at $43.25.

Volume traded for the day: 1.35 million shares.

Stock performance in the last month – up 6.53%; previous three-month period – up 15.12%; past twelve-month period – up 8.15%; and year-to-date – up 7.80%

After yesterday’s close, Hologic’s market cap was at $12.09 billion.

Price to Earnings (P/E) ratio was at 16.36.

The stock is part of the Healthcare sector, categorized under the Medical Appliances & Equipment industry. This sector was up 0.1% at the end of the session.

Active-Investors:

Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles, and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

A-I has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charter-holder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://active-investors.com/legal-disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@active-investors.com

Phone number: 73 29 92 6381

Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active-Investors

ReleaseID: 484854

LONDON, UK / ACCESSWIRE / December 22, 2017 / Active-Investors.com has just released a free earnings report on Humana Inc. (NYSE: HUM). If you want access to this report all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=HUM . The Company posted its financial results on November 08, 2017, for the third quarter of the fiscal year 2017. The Louisville, Kentucky-based Company’s non-GAAP earnings per share (EPS) grew on a y-o-y basis, outperforming Wall Street’s estimates. Register today and get access to over 1000 Free Research Reports by joining our site below:

www.active-investors.com/registration-sg

Active-Investors.com is focused on giving you timely information and the inside line on companies that matter to you. This morning, Humana most recent news is on our radar and our team decided to put out a fantastic report on the company that is now available for free below:

www.active-investors.com/registration-sg/?symbol=HUM

Earnings Highlights and Summary

During Q3 FY17, Humana posted total revenues of $13.28 billion, down from the $13.69 billion recorded at the end of Q3 FY16. The Company’s total revenue numbers missed market expectations of $13.29 billion. Total premium revenues were $12.96 billion compared to $13.37 billion in the last year’s same quarter, while total services revenues came in at $223 million in Q3 FY17 versus $227 million in Q3 FY16. Furthermore, Investment income revenues amounted to $104 million in the reported quarter, up from $96 million in Q3 FY16.

The insurer reported a net income of $499 million, or $3.44 per diluted share, in Q3 FY17, up from $450 million, or $2.98 per diluted share, in Q3 FY16. Furthermore, the Company’s adjusted diluted EPS rose to $3.39 million for Q3 FY17 from $3.20 million in the last year’s comparable quarter. Meanwhile, Wall Street had expected Humana to report an adjusted diluted EPS of $3.27.

Operating Metrics

For the three months ended September 30, 2017, the Company reported benefits expenses of $10.64 billion compared to $10.90 billion in the prior year’s corresponding quarter. The Company’s total operating expenses stood at $12.42 billion for the reported quarter compared to $12.75 billion in Q3 FY16. Furthermore, the Company reported income from operations of $858 million in Q3 FY17 versus $949 million in Q3 FY16.

Segment Performance

During Q3 FY17, Humana’s Retail segment’s total premiums and services revenue came in at $11.02 billion compared to $10.81 billion in Q3 FY16. The segment reported income before taxes of $610 million in Q3 FY17 compared to $608 million in the previous year’s same quarter. Additionally, the segment’s operating cost ratio stood at 9.8% in Q3 FY17 versus 10.6% in Q3 FY16.

Humana’s Group and Specialty segment generated total premiums and services revenue of $1.84 billion in Q3 FY17, which came in above the $1.82 billion of the last year’s same quarter. The segment’s income before taxes surged to $93 million in the reported quarter from $37 million in Q3 FY16. Furthermore, the segment’s operating cost ratio fell to 20.9% in Q3 FY17 from 23.1% in Q3 FY16.

Humana’s Healthcare Services segment posted total services and intersegment revenues of $5.99 billion in Q3 FY17 compared to $6.40 billion in Q3 FY16. The segment’s income before taxes was $240 million for reported quarter versus $297 million in Q3 FY16. Furthermore, the segment’s operating cost ratio rose to 95.6% in Q3 FY17 from 94.9% in Q3 FY16.

Balance Sheet

The Company’s net cash provided by operating activities was $6.96 billion in the first nine months of FY17 versus $4.71 billion in the prior year’s comparable period. The Company had a cash and cash equivalents balance of $9.87 billion as on September 30, 2017, compared to $3.88 billion at the close of books on December 31, 2016. Furthermore, the Company posted a long-term debt $3.98 billion as on September 30, 2017, versus $3.79 billion as on December 31, 2016.

Dividend and Share Repurchase

In a separate press release on November 02, 2017, Humana’s Board of Directors declared a cash dividend of $0.40 per share, payable on January 26, 2018, to stockholders of record as of the close of business on December 29, 2017.

On December 14, 2017, the Company’s Board of Directors approved a $3 billion share repurchase authorization with an expiration date of December 31, 2020, replacing its previous $2.25 billion share repurchase authorization.

Stock Performance Snapshot

December 21, 2017 – At Thursday’s closing bell, Humana’s stock marginally declined 0.64%, ending the trading session at $243.58.

Volume traded for the day: 889.40 thousand shares.

Stock performance in the last month – up 3.03%; previous three-month period – up 1.88%; past twelve-month period – up 21.91%; and year-to-date – up 19.38%

After yesterday’s close, Humana’s market cap was at $35.13 billion.

Price to Earnings (P/E) ratio was at 19.17.

The stock has a dividend yield of 0.66%.

The stock is part of the Healthcare sector, categorized under the Health Care Plans industry. This sector was up 0.1% at the end of the session.

Active-Investors:

Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles, and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

A-I has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charter-holder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://active-investors.com/legal-disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@active-investors.com

Phone number: 73 29 92 6381

Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active-Investors

ReleaseID: 484855

Over 40 Years of Financial Management Expertise

TAMPA, FL / ACCESSWIRE / December 22, 2017 / Znergy Inc. (OTC PINK: ZNRG) (the “Company”), a provider of energy efficient lighting products, lighting controls, and energy management solutions, announced today the appointment of William McMahon as Interim Chief Financial Officer. Mr. McMahon brings over 40 years of financial management experience, including as Chief Financial Officer in a variety of industries for public and private small and medium-size businesses.

Since early 2017, Mr. McMahon has been a principal in Nperspective CFO & Strategic Services, a fractional CFO company which provides interim and part-time CFO services. Since 2012, Mr. McMahon has been providing part-time CFO services to Neptune Minerals, Inc., a company engaged in deep ocean minerals exploration and resource development. From August 2015 to September 2016, Mr. McMahon was Chief Financial Officer and Treasurer for Rock Creek Pharmaceuticals, Inc., a drug development company focused on the development of new drugs and compounds that provide therapies for chronic inflammatory diseases such as psoriasis. During his 40 plus year career, Mr. McMahon has served as Chief Financial Officer, Controller and Treasurer for various small to medium size public and private companies. Mr. McMahon has a diverse industry background working in manufacturing, distribution, transportation and logistics, retail and hospitality, as well as LED lamp manufacturing. His background includes working with customers and suppliers internationally, including Europe, China, Africa, and Asia. Mr. McMahon holds a Bachelor of Science in Accounting degree from DePaul University in Chicago.

About Znergy, Inc.

Znergy, Inc. (OTC Markets: ZNRG) is a provider of energy efficient lighting products, lighting controls, and energy management solutions. Management is executing a growth strategy through developing large regional and national accounts, rolling out sales and installation teams across the United States. Our solutions enable customers to reduce energy consumption, lower maintenance costs and realize environmental benefits. Znergy is headquartered in Tampa, Florida. For more information, please visit: www.znergyworld.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements other than statements of historical facts included in this press release are forward-looking statements. These statements relate to future events or to the Company’s future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Investors should not place any undue reliance on forward-looking statements since they involve known and unknown, uncertainties and other factors which are, in some cases, beyond the Company’s control which could, and likely will materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects the Company’s current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to operations, results of operations, growth strategy and liquidity. Such risks, uncertainties, and other factors, which could impact the Company and the forward-looking statements contained herein are included in the Company’s filings with the Securities and Exchange Commission. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

Contact Information

Hayden IR
(917) 658-7878
hart@haydenir.com

SOURCE: Znergy Inc.

ReleaseID: 484863